Literature DB >> 639224

Lactic dehydrogenase isoenzyme determination in the diagnosis of acute myocardial infarction.

G Vasudevan, D W Mercer, M A Varat.   

Abstract

Lactic dehydrogenase (LD) isoenzymes were determined by a rapid, simple technique and their utility in the diagnosis of acute myocardial infarction (AMI) was evaluated. LD isoenzymes were separated by ion-exchange column chromatography using DEAE-Sephadex. The cardiac fractions (LD-1 and LD-2) were measured separately on an Abbott ABA-100 analyzer and ratio of LD isoenzyme 1 to LD isoenzyme 2 (LD1:2) calculated. Daily serum samples were obtained from 100 patients selected only for a history of chest pain of abrupt onset. In 47 patients whose diagnosis was acute myocardial infarction (AMI), confirmed by typical clinical presentation and typical rise in cardiac-specific creatine kinase isoenzyme (MB(, peak LD1:2 ranged from 0.77 to 2.26. In 44 patients without AMI, peak LD1:2 ranged from 0.25 to 0.76. In two patients with electrocardiographic changes chest pain occurred two and five days previously; there was no rise in MB, but LD1:2 was elevated. Four patients with small AMI had no rise in LD1:2. Three more patients (one with active hemolysis) had false positive results. Thus, there was a sensitivity of 96% and a specificity of 97% when the cut-off point was LD1:2 = 0.76. LD1:2 is not quite as sensitive or specific as MD, but the ratio allows for the diagnosis of infarction in cases where MB has already returned to normal.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639224     DOI: 10.1161/01.cir.57.6.1055

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Improving the early diagnosis of acute myocardial infarction.

Authors:  A Banerjee
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 2.  Biochemical markers of myocardial necrosis in acute myocardial infarction and thrombolysis.

Authors:  S Hornykewycz; H Gabriel; K Huber
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

3.  Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids.

Authors:  E M Ohman; K K Teo; A H Johnson; P B Collins; D G Dowsett; J T Ennis; J H Horgan
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

4.  Genome-wide linkage and association scans for quantitative trait Loci of serum lactate dehydrogenase-the framingham heart study.

Authors:  Jing-Ping Lin; Gang Zheng; Jungnam Joo; L Adrienne Cupples
Journal:  Hum Genomics Proteomics       Date:  2010-09-01

5.  Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.

Authors:  Xinye Li; Xiandu Pan; Yanda Li; Na An; Yanfen Xing; Fan Yang; Li Tian; Jiahao Sun; Yonghong Gao; Hongcai Shang; Yanwei Xing
Journal:  Crit Care       Date:  2020-07-28       Impact factor: 9.097

6.  5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action.

Authors:  Mantas Grigalavicius; Somayeh Ezzatpanah; Athanasios Papakyriakou; Tine Therese Henriksen Raabe; Konstantina Yannakopoulou; Theodossis A Theodossiou
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

7.  Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.

Authors:  Zeming Liu; Jinpeng Li; Man Li; Sichao Chen; Rongfen Gao; Guang Zeng; Danyang Chen; Shipei Wang; Qianqian Li; Di Hu; Wen Zeng; Liang Guo; Xiaohui Wu
Journal:  ESC Heart Fail       Date:  2020-12-17

Review 8.  COVID-19 and multiorgan failure: A narrative review on potential mechanisms.

Authors:  Tahmineh Mokhtari; Fatemeh Hassani; Neda Ghaffari; Babak Ebrahimi; Atousa Yarahmadi; Ghomareza Hassanzadeh
Journal:  J Mol Histol       Date:  2020-10-04       Impact factor: 2.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.